#Biodegradable Scaffold Market Insights | Explore Tumblr Posts and Blogs

poojascmi · 1 year

Text

Global Biodegradable Scaffold Market Is Estimated To Witness High Growth Owing To Rising Demand for Regenerative Medicine

The global Biodegradable Scaffold Market is estimated to be valued at US$1.02 billion in 2021 and is expected to exhibit a CAGR of 18% over the forecast period of 2022 to 2031, as highlighted in a new report published by Coherent Market Insights. A) Market Overview: Biodegradable scaffolds are three-dimensional structures designed to support cell growth and tissue regeneration. These scaffolds provide a temporary framework for cells to attach and grow, ultimately promoting new tissue formation. They are used in various applications such as bone tissue engineering, wound healing, cardiovascular repair, and organ transplantation. The advantage of biodegradable scaffolds is that they eliminate the need for surgical removal since they degrade naturally in the body over time. The increasing prevalence of chronic diseases and the growing demand for regenerative medicine are driving the market growth. B) Market Key Trends: One key trend observed in the biodegradable scaffold market is the rising demand for regenerative medicine. Regenerative medicine aims to restore the structure and function of damaged tissues or organs by using a combination of biomaterials, cells, and growth factors. Biodegradable scaffolds play a crucial role in this field by providing a platform for cell attachment, proliferation, and differentiation. They act as a temporary support system until the body's own cells can regenerate the tissue. For example, in bone tissue engineering, biodegradable scaffolds help stimulate new bone formation and facilitate the healing process. This trend is driven by the increasing geriatric population, rising prevalence of chronic diseases, and advancements in stem cell research. C) PEST Analysis: - Political: Government regulations and policies regarding the use of biodegradable materials and tissue engineering technologies can impact market growth. - Economic: The economic stability of a region influences investments in healthcare infrastructure and research and development activities in the field of regenerative medicine. - Social: The acceptance and awareness of regenerative medicine among the general population and healthcare professionals influence the adoption of biodegradable scaffolds. - Technological: Advancements in 3D printing, nanotechnology, and biomaterials have enabled the development of innovative and more effective biodegradable scaffolds. D) Key Takeaways: - The Global Biodegradable Scaffold Market Size is expected to witness high growth, exhibiting a CAGR of 18% over the forecast period, due to increasing demand for regenerative medicine. - North America is anticipated to be the fastest-growing and dominating region in the market, driven by well-established healthcare infrastructure, high healthcare expenditure, and supportive government initiatives. - Key players operating in the global biodegradable scaffold market include Merck KGaA, 3D Biotek LLC, Medtronic, Xanofi, Akron Biotech, Nanofiber Solutions, Vericel Corporation, NuVasive, Inc., Organogenesis, Inc., Biostage, Inc., In2Bones Global, Orthofix Medical Inc., Spine Smith, Invivo Therapeutics Holdings Corp., and Onkos Surgical. These companies focus on strategic collaborations, acquisitions, and product innovations to strengthen their market position. In conclusion, the global biodegradable scaffold market is expected to witness significant growth driven by the rising demand for regenerative medicine. The use of biodegradable scaffolds in tissue engineering applications provides a promising approach for facilitating tissue regeneration and improving patient outcomes. The market is characterized by technological advancements in biomaterials and 3D printing techniques, which enable the development of more advanced and personalized scaffolds. Regionally, North America is expected to be the fastest-growing market due to favorable healthcare infrastructure and government support. Key players in the market continue to invest in research and development activities to launch innovative products and gain a competitive edge.

#Biodegradable Scaffold Market #Biodegradable Scaffold Market Insights #Biodegradable Scaffold Market Trends #Biodegradable Scaffold Market Analysis #tissue regeneration #scaffolds #healthcare expenditure #cardiovascular disease #orthopedic disorders #Coherent Market Insights

0 notes

tamanna31 · 13 days

Text

Coronary Stents Market Key Vendors, Manufacturers, Suppliers and Analysis Industry Report 2030

Coronary Stents Industry Overview

The global coronary stents market size was estimated at USD 9.32 billion in 2022 and is expected to grow a compound annual growth rate (CAGR) of 3.1% from 2023 to 2030.

Growing aging population and a rising prevalence of noncommunicable diseases such as cardiovascular diseases (CVDs), complex lesions, diabetes, obesity, and others are expected to drive demand for coronary stents over the forecast period. According to the World Health Organization (WHO), in 2019, CVDs were among the major causes of mortality worldwide of which ischemic heart disease (IHD) ranks as the most prevalent. In 2019, an estimated 17.9 million people died from CVDs, responsible for 32% of worldwide mortalities.

Gather more insights about the market drivers, restrains and growth of the Coronary Stents Market

According to research published by the National Library of Medicine in June 2021, one of the CVDs, coronary artery disease (CAD), causes roughly 6,10,000 fatalities yearly (an estimated 1 in 4 deaths) and is the major cause of mortality in the U.S. As a result, the unprecedented rise in CAD incidence is predicted to boost demand for an effective coronary stent device for treatment. This factor is expected to bolster the demand throughout the forecast period. Since a coronary stent is used in most of the Percutaneous Coronary Intervention (PCI) procedures.

The rising preference for minimally invasive surgeries (MIS) is another factor expected to boost the adoption of coronary stents over the forecast period. The advantages of these procedures include small incision wounds leading to higher patient satisfaction. These procedures also provide shorter hospital stays and facilitate quick recovery. Stenting technology is increasingly preferred over the conventional balloon angioplasty owing to the introduction of advanced DES and evolving bioresorbable scaffolds. Technological advancements in coronary stents, such as the development of bifurcated stents and the use of biodegradable materials, have led to efficient and improved outcomes of CVD treatment. Companies are proactively involved in product developments and partnerships and strategic collaborations. The aforementioned factors are expected to propel market growth over the forecast period.

The impact of COVID-19 on the market for coronary stents closely tracked the impact of COVID-19 on overall PCI procedures. During the pandemic's initial outbreak and periods of high local COVID-19 case counts, several states, towns, and nations issued orders to citizens to shelter in place or minimize the potential exposure to and transmission of illness, resulting in elective surgeries being postponed. As a result, total PCI procedure volumes-and hence coronary stent unit sales and revenues-went significantly lower in 2020. These revenues are expected to rise as facility capacity usage improves and resumes all the semi-elective to non-urgent procedures.

The notable competitors in the market for coronary stents announced revenue falls in their interventional cardiology portfolios, which include coronary stent devices, in 2020, due to the impact of the COVID-19 pandemic. Boston Scientific, for instance, reported a significant decrease in annual revenues in its Interventional Cardiology segment, which includes coronary stent devices, in 2020, but the company performed relatively well in the first quarter of 2021, reporting revenue growth of approximately 7% globally compared to the first quarter of 2020. In contrast, Abbott Laboratories Laboratories was the least affected, with less impact on its entire vascular segment in 2020, which includes coronary stent devices, in its 2020 annual results.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global disposable hospital gowns market size was valued at USD 3.68 billion in 2023 and is projected to grow at a CAGR of 12.9% from 2024 to 2030.

• The global knee braces market size was valued at USD 1.12 billion in 2023 and is projected to grow at a CAGR of 7.7% from 2024 to 2030.

Competitive Insights

Product launches, approvals, strategic acquisitions, and innovations are some of the crucial business strategies adopted by market participants to maintain and grow their global reach. Abbott Laboratories, Boston Scientific, and Medtronic accounted for a significant presence in the overall market. These companies have gained a notable presence in the market due to good strong performances in the lucrative DES market and large product portfolios spanning numerous different IC device categories. For instance, in August 2022, Medtronic launched the Onyx Frontier drug-eluting stent (DES). The new product offers advanced delivery management and improves the overall performance in the most challenging cases.

Despite the dominance of the three major manufacturers, the market for coronary stents is a blend of numerous global and local players. BIOTRONIK, for instance, has been able to establish a significant presence in the entire market by offering low pricing and new technologies that address unmet needs. Positive clinical results from BIOTRONIK's BIONYX, BIOFLOW-V, and BIOSOLVE trials, in conjunction with the use of BIOTRONIK's Orsiro DES and Magmaris BRS, have positioned the company well to compete against the market's largest players. BIOTRONIK is also one of the most competitive players in the overall BRS device market. Terumo Corporation, Biosensors International, and Cardinal Health are a few additional significant competitors in this market. Some of the prominent players in the global coronary stents market include:

Abbott

Medtronic

Boston Scientific Corporation

Terumo Corporation

B Braun Melsungen AG

Biotronik

Stentys SA

MicroPort Scientific Corporation

C. R. Bard, Inc.

Cook Medical

Order a free sample PDF of the Coronary Stents Market Intelligence Study, published by Grand View Research.

0 notes

omshinde5145 · 24 days

Text

Biomedical Textiles Market Trends, Review, and Forecast 2024–2030

The Biomedical Textiles Market was valued at USD 18.8 billion in 2023-e and will surpass USD 52.7 billion by 2030; growing at a CAGR of 15.9% during 2024 - 2030. In the ever-evolving landscape of healthcare, the biomedical textiles market stands out as a beacon of innovation and progress. These advanced materials, designed for medical and biological applications, are revolutionizing the way we approach patient care, from wound management to implantable devices. As we delve into the intricacies of this burgeoning market, it becomes clear that biomedical textiles are not just a trend but a fundamental shift in medical technology.

Biomedical textiles are a subset of technical textiles specifically engineered for medical purposes. These textiles include fibers, yarns, fabrics, and composites that are biocompatible and designed to interact with biological systems. They are utilized in a variety of medical applications, including:

Wound Care: Dressings, bandages, and scaffolds that promote healing and reduce infection risks.

Implantable Devices: Sutures, vascular grafts, stents, and artificial organs that integrate seamlessly with the human body.

Healthcare and Hygiene Products: Hospital linens, surgical gowns, and masks that ensure a sterile environment.

Tissue Engineering: Scaffolds that support the growth and development of new tissues and organs.

Get a Sample Report: https://bit.ly/3WIbls9

Market Dynamics

The biomedical textiles market is experiencing robust growth, driven by several key factors:

Aging Population

The global population is aging, leading to an increased demand for medical care and devices. Biomedical textiles play a crucial role in managing chronic conditions, enhancing the quality of life for elderly patients, and reducing the burden on healthcare systems.

Technological Advancements

Innovations in materials science and textile engineering are propelling the market forward. Developments in nanotechnology, smart textiles, and biocompatible materials are opening new avenues for biomedical applications, making treatments more effective and less invasive.

Rising Prevalence of Chronic Diseases

The incidence of chronic diseases such as diabetes, cardiovascular diseases, and cancer is on the rise. Biomedical textiles are essential in the management and treatment of these conditions, providing solutions that range from wound care to advanced implantable devices.

Increased Healthcare Spending

Governments and private sectors are investing heavily in healthcare infrastructure and technologies. This financial influx is boosting research and development in biomedical textiles, leading to the creation of more sophisticated and effective medical products.

Key Players and Innovations

Several companies are at the forefront of the biomedical textiles market, driving innovation and expanding their product portfolios. Notable players include Medtronic, Johnson & Johnson, B. Braun Melsungen, and Cardinal Health. These companies are investing in research and development to create cutting-edge products that address unmet medical needs.

Innovations in the field include:

Smart Textiles: Fabrics embedded with sensors and actuators that monitor vital signs and deliver therapeutic interventions.

Biodegradable Textiles: Materials that degrade naturally within the body, eliminating the need for surgical removal.

Antimicrobial Textiles: Fabrics treated with antimicrobial agents to prevent infections and promote healing.

Get an insights of Customization: https://bit.ly/4d6aB5S

Challenges and Future Prospects

Despite the promising growth, the biomedical textiles market faces several challenges. Regulatory hurdles, high costs of advanced materials, and the need for extensive clinical trials can slow down the pace of innovation. Additionally, the integration of new technologies into existing healthcare systems requires significant investment and adaptation.

However, the future of biomedical textiles is bright. With continuous advancements in materials science, biotechnology, and medical engineering, the market is poised for exponential growth. Emerging trends such as personalized medicine, regenerative medicine, and minimally invasive surgeries will further drive the demand for innovative biomedical textiles.

Conclusion

The biomedical textiles market is a dynamic and rapidly evolving sector that holds immense potential for transforming healthcare. By addressing the needs of an aging population, advancing technological innovations, and providing solutions for chronic diseases, biomedical textiles are set to play a pivotal role in the future of medicine. As we look ahead, the integration of these advanced materials into mainstream healthcare promises to enhance patient outcomes, improve quality of life, and pave the way for a healthier future.

#Biomedical Textiles #Biomedical Textiles Size #Biomedical Textiles Trends #Biomedical Textiles Outlook

0 notes

tmr-blogs2 · 3 months

Text

Ceramic-Polymer Composites for Biomedical Applications Market to Reach US$ 536.8 Mn by 2031

The ceramic-polymer composites for biomedical applications market was valued at US$ 243.1 Mn in 2022 and is projected to reach US$ 536.8 Mn by 2031 at a CAGR of 9.2% from 2023 to 2031.

Rapidly increasing usage of ceramic-polymer composites in a range of implants, prosthetics, and biomedical devices is a key trend expected to propel the market. Rise in utilization of ceramic-polymer composites as orthopedic implants can be ascribed to several suitable structural and functional properties of these composites, including bone-bonding capability, mechanical & bioactive properties, and biocompatibility.

Request for a Sample PDF Report with Latest Industry Insights - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85536

Surge in adoption of ceramic-polymer composites in tissue generation applications and drug delivery applications is anticipated to offer significant opportunities for companies. Rise in R&D in 3D and 4D printing technologies is anticipated to pave the way to multifunctional scaffolds for use in bone tissue regeneration applications. Continuous advancements in fabrication techniques of nanofillers and composites are expected to broaden market outlook. Companies are focusing on the development of novel bioresorbable composite materials that can be used in the treatment of chronic bone conditions. For instance, the potential of biodegradable polymer matrix in curing chronic osteomyelitis has increased interest among several companies.

Key Findings of Study

Rise in Preference for Hydroxyapatite-based Composites: In terms of bioactive ceramic type, the hydroxyapatite segment is likely to account for major market share during the forecast period. Hydroxyapatite-based composites are widely used in orthopedic and dental implants, as these possess remarkable bioactivity and biocompatibility, in addition to mechanical properties. Rise in adoption of hydroxyapatite-based composites in tissue engineering applications is likely to bolster the ceramic-polymer composites for biomedical applications market.

Surge in Demand for Ceramic-Polymer Composites for Orthopedic & Dental Implants: Adoption of ceramic-polymer composites for biomedical applications is driven by surge in utilization of these materials in orthopedic procedures. Recent market trends indicate that these have also been widely adopted as biomaterials for bone reconstruction in a number of dental procedures.

Key Drivers

Rise in demand for orthopedic and dental implants to treat a range of bone defects and dental procedures is a key driver of the global ceramic-polymer composites for biomedical applications market

Advancements in polymer composite technologies, such as the application of 3D printing, melt extrusion-based additive manufacturing technology, and nanotechnology, are likely to propel the market. Utilization of these technologies has resulted in significant market prospects for biodegradable polymer matrix nanocomposites in tissue engineering applications.

The surge in demand for advanced regenerative therapies is likely to increase applications in the ceramic-polymer composites for biomedical applications market

Rise in the prevalence of osteoarthritis is likely to bolster the adoption of ceramic-polymer composites

Regional Growth Dynamics

Asia Pacific accounted for the major market share in 2022. The region is anticipated to dominate the global market from 2023 to 2031. Rise in healthcare infrastructure investment by governments & private companies and rapid expansion of medical tourism are key trends expected to augment market value in Asia Pacific during the forecast period.

Brazil, South Africa, and Australia are projected to be lucrative markets for ceramic-polymer composites for biomedical applications. North America and Europe are expected to record significant revenue in the next few years owing to surge in adoption of orthopedic and dental implants.

Competition Landscape

Key companies are focusing on developing ceramic-polymer composites with enhanced structural and functional properties. They are also focusing on improving the biocompatibility of these by fabricating organic-inorganic composites such as collagen fibers, fabrics, and films in order to cater to the rise in demand for medical implants in orthopedics.

Prominent companies in the ceramic-polymer composites for biomedical applications market are Foster Corporation, TA Instruments, Metoxit, Zimmer Biomet, Stryker Corporation, CeramTec GmbH, DSM, CAM Bioceramics BV, Morgan Advanced Materials, and CoorsTek Medical LLC.

Ceramic-Polymer Composites for Biomedical Applications Market Segmentation

Bioactive Ceramics Type

Bioglass

Titania

Zirconia

Alumina

Hydroxyapatite (HA)

Composition

Solid

Fibers

Gels

Fabrics and Films

Others

Application

Tissue Engineering

Dental Implants

Orthopedic Implants

Drug Delivery

Others

Region

North America

Europe

Latin America

Asia Pacific

Middle East & Africa

Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=85536&ltype=S

About Transparency Market Research

Transparency Market Research, a global market research company registered in Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com

0 notes

gqresearch24 · 6 months

Text

3D Printing in Healthcare market To Witness the Highest Growth Globally In Coming Years 2024-2030 | GQ Research

The 3D Printing in Healthcare market is set to witness remarkable growth, as indicated by recent market analysis conducted by GQ Research. In 2023, the global 3D Printing in Healthcare market showcased a significant presence, boasting a valuation of US 1448.10 Billion. This underscores the substantial demand for 3D Printing in Healthcare technology and its widespread adoption across various industries.

Get Sample of this Report at: https://gqresearch.com/request-sample/global-3d-printing-in-healthcare-market/

Projected Growth: Projections suggest that the 3D Printing in Healthcare market will continue its upward trajectory, with a projected value of US$ 6052.50 Billion by 2030. This growth is expected to be driven by technological advancements, increasing consumer demand, and expanding application areas.

Compound Annual Growth Rate (CAGR): The forecast period anticipates a Compound Annual Growth Rate (CAGR) of 19.85 %, reflecting a steady and robust growth rate for the 3D Printing in Healthcare market over the coming years.

Technology Adoption:

Increasing adoption of 3D printing technology for various healthcare applications.

Utilization in prosthetics, implants, surgical tools, and anatomical models.

Customization and rapid prototyping capabilities revolutionizing patient care.

Application Diversity:

Production of patient-specific implants and medical devices tailored to individual anatomy.

Creation of anatomical models for surgical planning, medical education, and training.

Printing of drug delivery systems and tissue engineering scaffolds for regenerative medicine.

Consumer Preferences:

Demand for personalized healthcare solutions to improve patient outcomes.

Preference for cost-effective and time-efficient manufacturing of medical devices and implants.

Emphasis on quality, safety, and regulatory compliance of 3D-printed healthcare products.

Technological Advancements:

Advancements in bioprinting for the fabrication of living tissues and organs.

Development of high-resolution 3D printers capable of printing intricate structures with bio-compatible materials.

Integration of imaging technologies such as MRI and CT scans for patient-specific designs.

Market Competition:

Intense competition among 3D printer manufacturers and healthcare companies.

Differentiation through innovation in materials, printing techniques, and software solutions.

Strategic partnerships with medical institutions and research organizations.

Focus on regulatory approval and reimbursement strategies to gain market share.

Environmental Considerations:

Potential reduction of medical waste through on-demand manufacturing and customization.

Exploration of eco-friendly and biodegradable materials for 3D printing.

Consideration of energy consumption and environmental impact during the printing process.

Ethical considerations regarding the use of 3D printing for human tissue and organ transplantation.

Regional Dynamics: Different regions may exhibit varying growth rates and adoption patterns influenced by factors such as consumer preferences, technological infrastructure and regulatory frameworks.

Key players in the industry include:

Formlabs Inc.

General Electric

3D Systems Corporation

Exone Company

Materialise NV

Oxferd Performance Materials Inc.

SLM Solutions Group AG

Organovo Holdings Inc.

Proto Labs

Stratasys Ltd.

The research report provides a comprehensive analysis of the 3D Printing in Healthcare market, offering insights into current trends, market dynamics and future prospects. It explores key factors driving growth, challenges faced by the industry, and potential opportunities for market players.

For more information and to access a complimentary sample report, visit Link to Sample Report: https://gqresearch.com/request-sample/global-3d-printing-in-healthcare-market/

About GQ Research:

GQ Research is a company that is creating cutting edge, futuristic and informative reports in many different areas. Some of the most common areas where we generate reports are industry reports, country reports, company reports and everything in between.

Contact:

Jessica Joyal

+1 (614) 602 2897 | +919284395731

Website - https://gqresearch.com/

#3DPrintingHealthcare #AdditiveManufacturing #PersonalizedMedicine #MedicalInnovation #HealthTech

0 notes

shristisahu · 7 months

Text

Revolutionizing Healthcare: High-Performance Biomaterials Market Analysis 2024-2028

Originally Published on: Technavio High Performance Biomaterials Market Analysis North America, Europe, APAC, South America, Middle East and Africa - US, China, Japan, Germany, UK - Size and Forecast 2024-2028

The high-performance biomaterials market is on the brink of significant growth, projecting a USD 8.48 billion increase with a CAGR of 11.29% between 2023 and 2028. Key drivers encompass the prevalence of musculoskeletal and dental diseases, a surge in joint replacement surgeries, and advancements in regenerative medicine. This exhaustive report examines drivers, trends, and challenges, drawing insights from historical data (2018-2022) and scrutinizing the current market scenario.

Market Size Anticipation During the Forecast Period

High-Performance Biomaterials Market Size

Market Dynamics

Researchers base their analysis on 2023 data, delving into growth factors, trends, and challenges. A holistic understanding empowers companies to refine marketing strategies for a competitive edge.

Key Driver: Rising Prevalence of Dental Diseases

The increasing prevalence of dental diseases, coupled with musculoskeletal and chronic skeletal conditions, propels biomaterials market growth. Biomaterial-based implants and orthopedic solutions cater to prosthetic demands, driving substantial market growth.

Significant Trends: Focus on Regenerative Medicine

Progressive research in regenerative medicine serves as scaffolds in tissue repair and regrowth. Biomaterials in regenerative medicine facilitate cell proliferation, encourage biological signals, and provide structural support.

Major Challenge: Safety and Mechanical Strength

Safety and mechanical strength challenges arise concerning material corrosion, infection risks, and issues during prolonged in vivo use. Careful consideration in biomaterial development is crucial, affecting market growth.

Segmentation by Type, Application, and Geography

Type Analysis

Market Share Growth: Metallic Segment

The metallic segment projects significant growth due to excellent thermal conductivity and mechanical properties. Metallic biomaterials find extensive use in biomedical devices, orthopedic surgical procedures, and dental surgeries.

Application Analysis

Dominance of Orthopedics Segment

The orthopedics segment is expected to dominate, aiding joint replacements, bone grafting, and tissue repair. Technological advancements, including 3D printing and biodegradable materials, fuel market growth for orthopedic biomaterials.

Region Analysis

North America's Dominance

North America is estimated to contribute 38% to global market growth, driven by prevalent orthopedic disorders, advanced medical device adoption, and supportive regulatory environments.

Market Definition

High-performance biomaterials, derived from synthetic, natural, and other sources, aim to restore or replace human organs or tissues. These materials find applications in medical devices, implants, and tissue engineering scaffolds.

Key Companies

Companies employ various strategies, including alliances, mergers, acquisitions, and geographical expansion, to enhance market presence. Advanced Medical Solutions Group Plc, with its subsidiary Biomatlante SA, is a key player in biomaterials for orthopedic, spinal, dental, and sports surgery.

Market Analyst Overview

The market witnesses significant growth, driven by the increasing prevalence of musculoskeletal and chronic skeletal medical conditions. Technological advancements in biomaterials reshape the healthcare landscape, offering innovative solutions.

Segment Overview

The market predicts growth globally, regionally, and at country levels, analyzing trends and growth opportunities from 2018-2028.

Type Outlook

Metallic

Polymers

Ceramic

Application Outlook

Orthopedics

Dental

Cardiovascular

Plastic surgery

Tissue engineering and others

Region Outlook

North America

Europe

APAC

South America

Middle East & Africa

Conclusion

The trajectory of the high-performance biomaterials market underscores the significance of innovative biomaterials in shaping the future of healthcare. These materials offer tailored solutions to diverse clinical needs, advancing patient outcomes and improving the quality of life.

#HighPerformanceBiomaterials #HealthcareInnovation #RegenerativeMedicine #MedicalTechnology #MarketAnalysis

0 notes

chemicalresearchupdates · 10 months

Text

Exploring the Dynamics of the Medical Polymers Market: A Comprehensive Industry Overview

The Medical Polymers Market is estimated to be valued at US$ 22.13 Bn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:

Medical polymers are used in various medical devices, kits, implants and consumables due to their superior mechanical properties, chemical resistance and compatibility with human tissues. Some key properties of medical polymers include biocompatibility, flexibility and durability. They are used to manufacture medical equipment such as catheters, surgical gloves, syringes, prosthetics and more. Polymers offer advantages like transparency, lightweight and durability required for medical components. Market Key Trends:

Demand for biodegradable polymers is increasing due to strict environmental regulations regarding disposal of conventional polymers. Biodegradable polymers such as polylactic acid (PLA) and polyglycolic acid (PGA) are gaining popularity as they can decompose in soil or water and do not leave any toxic residue. They are used in sutures, tissue engineering scaffolds and drug delivery systems as an alternative to traditional polymers. Researchers are also developing new biodegradable polymers derived from natural polymers like cellulose, collagen and silk, to reduce ecological footprint of medical polymers. Adoption of eco-friendly biodegradable polymers will be a major trend in the medical polymers market over the forecast period.

Porter’s Analysis:

Threat of new entrants: Low barriers to entry for starting new businesses in medical polymers. However, established brands have predominant market share and resources.

Bargaining power of buyers: Large medical device manufacturers have significant bargaining power due to their volume purchases. They can negotiate on price and demand high quality products.

Bargaining power of suppliers: A few major companies dominate the supply of key polymers like PEEK, PP, silicone etc. This gives them strong bargaining power over customers.

Threat of new substitutes: New biodegradable materials are emerging but compatibility issues and regulatory approvals are barriers. Traditional polymers still have advantages of durability and processing flexibility.

Competitive rivalry: Intense competition amongst key players to develop application-specific polymers and bundles of products and services. Capital investments in R&D are high.

SWOT Analysis:

Strength: Wide range of properties to suit diverse medical device needs. Processability into complex shapes using injection moulding or extrusion. Resistance to chemicals, sterilization and prolonged exposure in bodily tissues or fluids.

Weakness: Concerns over toxicity of certain additives and plasticizers used. Regulatory compliance adds to production costs. Limited capability for large-scale personalization.

Opportunity: Growth in implantable devices, surgical tools and diagnostics. Rising healthcare access in developing nations. Development of bio-based and resorbable materials.

Threats: Stringent regulatory norms. Shift to localized manufacturing may impact multinational firms. Developing substitutes like bioplastics.

Key Takeaways

The global medical polymers market is expected to witness high growth exhibiting CAGR of 10% over the forecast period, due to increasing demand for improved implant materials and single use surgical and medical devices. The market size for 2023 is estimated at US$ 22.13 Bn. The North America region currently dominates the medical polymers market share due to presence of major players and advanced healthcare infrastructure. Asia Pacific is projected to be the fastest growing region owing to increasing healthcare investments, lower production costs and rising medical tourism. Key players operating in the medical polymers market are BASF SE, Bayer MaterialScience AG, Celanese Corporation, DSM N.V., E. I. du Pont de Nemours Company, Eastman Chemical Company, ExxonMobil Corporation, Evonik Industries AG, and The Dow Chemical Company. These established brands continuously invest in product development to widen their portfolios and adapt to evolving regulatory standards.

#Medical Polymers Market #Medical Polymers Market Trends #Medical Polymers Market Growth

0 notes

priyanshisingh · 1 year

Text

Synthetic Bone Graft Substitutes Market Size, Analyzing Growth and Forecasting Outlook from 2023-2030

The latest market report published by Credence Research, Inc. “Global Synthetic Bone Graft Substitutes Market: Growth, Future Prospects, and Competitive Analysis, 2022 – 2030. The global demand for Synthetic Bone Graft Substitutes was valued at USD 1.1 Billion in 2022 and is expected to reach USD 1.74 Billion in 2030, growing at a CAGR of 6.80% between 2023 and 2030.

Synthetic Bone Graft Substitutes Market pertains to the medical industry's focus on developing and supplying synthetic materials that can serve as substitutes for traditional bone grafts in various medical procedures. Bone grafting is a common procedure used to repair bone defects, promote bone growth, and facilitate the healing process in cases of fractures, bone loss, spinal fusion surgeries, and orthopedic treatments. Synthetic bone graft substitutes offer several advantages over traditional methods, including reduced risk of disease transmission and availability of customizable materials with predictable properties.

Key Components and Types of Synthetic Bone Graft Substitutes:

Ceramics: Synthetic ceramics, such as calcium phosphate-based materials (hydroxyapatite and tricalcium phosphate), closely resemble the mineral component of natural bone. They provide a scaffold for new bone growth and are gradually replaced by the patient's own bone tissue.

Polymers: Biodegradable synthetic polymers, like polylactic acid (PLA) and polyglycolic acid (PGA), are used to create porous scaffolds that promote bone cell attachment and growth. These materials eventually degrade, leaving behind new bone tissue.

Calcium Sulfate: Calcium sulfate-based materials provide temporary support while promoting bone healing. They are often used in procedures where the goal is to facilitate bone regeneration without leaving a permanent implant.

Composite Materials: These are combinations of various synthetic materials, such as ceramics and polymers, to provide a balance of mechanical support and biocompatibility.

Growth Factors: Some synthetic bone graft substitutes are combined with growth factors to enhance bone regeneration by stimulating the body's natural healing processes.

List of the prominent players-

AlloSource

Baxter

DePuy Synthes

Medtronic

NuVasive, Inc.

Orthofix Medical, Inc.

Smith + Nephew

Stryker.

OST Laboratories

Zimmer Biomet

Geistlich Pharma AG

TBF

Biobank

Synthetic Bone Graft Substitutes Market exhibits varying trends and dynamics across different regions globally. Regional analysis of this market provides insights into the factors influencing demand, adoption, regulatory landscape, and market growth in specific geographic areas.

Here's an overview of the regional analysis of the Synthetic Bone Graft Substitutes Market:

North America:

North America has a mature healthcare infrastructure and is a key market for synthetic bone graft substitutes. Factors such as a large aging population, high prevalence of bone-related conditions, and advanced medical technologies drive the demand for these substitutes. The region also has a strong presence of medical device manufacturers and research institutions, contributing to ongoing innovation in the field. Regulatory agencies like the FDA (U.S. Food and Drug Administration) play a crucial role in product approvals and shaping market dynamics.

Europe:

Europe is another significant market for synthetic bone graft substitutes. The region's well-established healthcare systems, increasing awareness of advanced medical treatments, and emphasis on research and innovation contribute to market growth. Collaboration between academic institutions, hospitals, and manufacturers drives the development of new products. Regulatory bodies like the European Medicines Agency (EMA) and national health authorities influence product approvals and market entry.

Asia Pacific:

The Asia Pacific region is experiencing rapid growth in the healthcare sector, attributed to rising healthcare expenditure, increasing access to medical treatments, and a growing middle class. Countries like China and India are witnessing higher adoption of synthetic bone graft substitutes due to the prevalence of orthopedic surgeries and trauma cases. However, market dynamics can vary across countries with differing regulatory frameworks and healthcare systems.

Latin America:

Latin America presents opportunities for market growth due to improving healthcare infrastructure and increasing investments in medical technologies. The region's large population and the incidence of trauma-related injuries contribute to demand for bone graft substitutes. Regulatory processes and market penetration can vary by country, affecting the pace of market expansion.

Middle East and Africa:

The Middle East and Africa region is seeing investments in healthcare infrastructure and advancements in medical treatments. The demand for synthetic bone graft substitutes is influenced by factors such as population growth, an increase in chronic conditions, and medical tourism in certain countries. Variations in healthcare accessibility, regulatory environments, and economic conditions impact market dynamics.

Global Factors Impacting Regional Dynamics:

Technological Advances: Regions with strong research and development capabilities tend to lead in innovation and market adoption of advanced synthetic bone graft substitutes.

Demographics: The prevalence of aging populations and associated bone-related conditions can drive demand for bone grafting procedures and related products.

Healthcare Infrastructure: Well-established healthcare systems with access to advanced medical treatments tend to foster higher adoption of synthetic bone graft substitutes.

Regulatory Landscape: Regulatory agencies play a crucial role in product approvals and market entry, shaping market dynamics and adoption rates.

Economic Conditions: Economic factors, including healthcare spending, insurance coverage, and disposable income, influence market growth and adoption rates.

Disease Patterns: The prevalence of conditions like osteoporosis, fractures, and orthopedic surgeries in specific regions affects the demand for bone graft substitutes.

Cultural and Ethical Factors: Cultural attitudes towards medical treatments and surgery can impact the acceptance of synthetic bone graft substitutes.

Browse 180 pages report Synthetic Bone Graft Substitutes Market By Material (Wood, Plastic, Paper) By Application (Children, Adults) - Growth, Future Prospects & Competitive Analysis, 2016 – 2030)- https://www.credenceresearch.com/report/synthetic-bone-graft-substitutes-market

Synthetic Bone Graft Substitutes Market Dynamics-

Synthetic Bone Graft Substitutes Market are shaped by a complex interplay of various factors that impact its growth, trends, and overall trajectory. These dynamics encompass technological advancements, market demand, regulatory considerations, competitive landscape, and collaborations within the medical and healthcare industry. Gaining insights into these dynamics is essential for stakeholders seeking to navigate this market effectively.

Here's a comprehensive look at the key dynamics driving the Synthetic Bone Graft Substitutes Market:

Technological Advancements: Ongoing innovations in material science, biotechnology, and medical research are pivotal in driving the development of advanced synthetic bone graft substitutes. The introduction of novel materials with enhanced biocompatibility, structural integrity, and osteoinductive properties contributes to the market's evolution.

Rising Prevalence of Bone-related Conditions: The increasing incidence of bone fractures, degenerative bone diseases, and conditions like osteoporosis is driving the demand for synthetic bone graft substitutes. As the aging population grows and lifestyles change, the need for effective bone healing solutions is on the rise

Orthopedic Procedures and Surgeries: Synthetic bone graft substitutes find extensive use in orthopedic surgeries such as joint replacements, spinal fusions, and trauma treatments. The growth of these procedures directly influences the demand for bone graft substitutes as a means to promote bone healing and fusion.

Regulatory Landscape: Regulatory agencies such as the FDA, EMA, and regional health authorities play a critical role in approving and ensuring the safety of synthetic bone graft substitutes. Stringent regulations influence product development, testing, and market access, shaping the industry's standards and practices.

Market Competition and Innovation: The competitive landscape drives innovation as companies strive to develop differentiated and effective synthetic bone graft substitutes. R&D efforts focus on creating materials with improved biocompatibility, mechanical properties, and bioactivity.

Healthcare Infrastructure: Regions with well-established healthcare systems and access to advanced medical treatments tend to witness higher adoption of synthetic bone graft substitutes. Robust healthcare infrastructure contributes to the availability and acceptance of these advanced medical technologies.

Economic Factors: Economic conditions, healthcare spending, insurance coverage, and disposable income levels influence the affordability and accessibility of synthetic bone graft substitutes. Economic growth in regions often corresponds to increased adoption rates.

Benefits of Synthetic Bone Graft Substitutes:

Reduced Disease Transmission Risk: Unlike traditional bone grafts sourced from donors, synthetic substitutes eliminate the risk of disease transmission and immune rejection.

Predictable Properties: Synthetic grafts can be manufactured with consistent properties, allowing surgeons to select materials tailored to the patient's specific needs.

Availability: Synthetic materials can be produced in large quantities, reducing the need to rely on limited donor supply.

Customization: The properties of synthetic grafts can be adjusted to match the mechanical and biological requirements of different procedures.

Rapid Incorporation: Some synthetic materials facilitate faster bone healing by providing a scaffold for bone growth and promoting cell attachment.

Market Trends and Outlook:

The Synthetic Bone Graft Substitutes Market has been growing due to advancements in materials science, increased awareness of the benefits of synthetic grafts, and the rising prevalence of bone-related conditions.

Key trends and factors influencing the market include:

Technological Advancements: Ongoing research and development efforts are leading to the creation of innovative synthetic materials that closely mimic the structure and properties of natural bone.

Orthopedic Surgeries: The increasing number of orthopedic surgeries, such as joint replacements and spinal fusion procedures, is driving the demand for synthetic bone graft substitutes to aid in bone healing and fusion.

Aging Population: As the global population ages, the incidence of conditions like osteoporosis and fractures is rising, increasing the demand for bone grafting procedures and related products.

Regulatory Approvals: The approval and adoption of new synthetic bone graft substitute materials by regulatory authorities contribute to market growth.

Medical Tourism: The popularity of medical tourism and access to advanced medical treatments are expanding the market's reach in various regions.

Collaborative Research: Collaboration between medical device manufacturers, researchers, and medical professionals is leading to the development of improved synthetic graft materials.

Patient Preferences: Patients are increasingly interested in treatment options that offer faster recovery and reduced risk, which can drive demand for synthetic graft substitutes.

Cost-effectiveness: Synthetic graft substitutes may offer cost benefits compared to traditional bone grafts due to reduced risks, shorter hospital stays, and less invasive procedures.

Why to Buy This Report-

The report provides a qualitative as well as quantitative analysis of the global Synthetic Bone Graft Substitutes Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.

The report includes information on the competitive landscape, such as how the market's top competitors operate at the global, regional, and country levels.

Major nations in each region with their import/export statistics

The global Synthetic Bone Graft Substitutes Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major players analysis, market growth strategies, and key application areas.

Browse Full Report: https://www.credenceresearch.com/report/synthetic-bone-graft-substitutes-market

Visit: https://www.credenceresearch.com/

Related Report: https://www.credenceresearch.com/report/automated-and-rapid-microbiological-tests-market

Related Report: https://www.credenceresearch.com/report/remote-patient-monitoring-devices-market

Browse Our Blog: https://www.linkedin.com/pulse/synthetic-bone-graft-substitutes-market-size-forecasted-singh

About Us -

Credence Research is a viable intelligence and market research platform that provides quantitative B2B research to more than 10,000 clients worldwide and is built on the Give principle. The company is a market research and consulting firm serving governments, non-legislative associations, non-profit organizations, and various organizations worldwide. We help our clients improve their execution in a lasting way and understand their most imperative objectives. For nearly a century, we’ve built a company well-prepared for this task.

Office No 3 Second Floor, Abhilasha Bhawan, Pinto Park, Gwalior [M.P] 474005 India

0 notes

market-insider · 1 year

Text

Biomaterials: Enhancing Biocompatibility and Functionality

Biomaterials are materials that are specifically designed and engineered to interact with biological systems, such as living tissues and organs. They are used in various fields of medicine and healthcare to develop medical devices, implants, and regenerative therapies. Biomaterials can be synthetic or natural in origin and possess unique properties that allow them to be compatible with the human body, promoting healing, regeneration, or providing mechanical support. They are extensively researched and tailored to meet specific biomedical requirements, including biocompatibility, bioactivity, durability, and controlled degradation. Biomaterials play a crucial role in advancing medical treatments and improving patient outcomes by providing innovative solutions for repairing and replacing damaged or diseased tissues and organs.

Gain deeper insights on the market and receive your free copy with TOC now @: Biomaterials Market Report

The integration of 3D printing technology with biomaterials has revolutionized the field of tissue engineering and regenerative medicine. Researchers have made significant progress in printing complex, functional structures using biomaterials, enabling the creation of patient-specific implants, scaffolds, and organs. The ability to print with multiple materials and incorporate cells and growth factors has opened new possibilities for customized biomedical solutions. There has been a growing emphasis on developing biomaterials that are biodegradable and bioresorbable. These materials can degrade and be absorbed by the body over time, reducing the need for additional surgical procedures. Biodegradable polymers and scaffold materials have found applications in areas such as drug delivery systems, orthopedics, and wound healing. The development of smart biomaterials involves incorporating responsive elements, such as sensors, actuators, and drug release systems, into the material matrix. These materials can sense changes in their environment and respond accordingly. For example, smart hydrogels can change their properties in response to temperature, pH, or electrical signals, enabling controlled drug release or tissue engineering applications.

Nanotechnology has made significant contributions to the field of biomaterials, enabling precise control at the nanoscale. Nanomaterials offer unique properties, such as increased surface area, improved mechanical strength, and enhanced bioactivity. They have been used in applications ranging from drug delivery systems to tissue engineering scaffolds, allowing for better control over cellular interactions and tissue regeneration. Researchers are increasingly drawing inspiration from nature to develop biomaterials with enhanced properties. For example, biomaterials mimicking the structure and properties of natural tissues, such as bone or cartilage, have shown promise in promoting tissue regeneration. Bio-inspired materials also seek to replicate the dynamic and responsive characteristics found in living systems, leading to innovative approaches in wound healing, drug delivery, and tissue engineering.

Surface modification techniques are being explored to improve the biocompatibility and functionality of biomaterials. These techniques involve altering the surface properties of biomaterials at the nanoscale to enhance cellular interactions, reduce inflammation, and prevent infections. Surface modifications can include the incorporation of bioactive molecules, such as growth factors or antimicrobial agents, or the creation of nanostructures that promote specific cellular responses.

#Biomaterials Market Size & Share #Global Biomaterials Market #Biomaterials Market Latest Trends #Biomaterials Market Growth Forecast #COVID-19 Impacts On Biomaterials Market #Biomaterials Market Revenue Value

0 notes

stratviewresearch · 2 years

Text

Polyglycolic Acid (PGA) Market to Witness a Pronounce Growth at CAGR during 2027

Stratview Research delivers key insights on the global Polyglycolic Acid (PGA) Market. According to Stratview Research, the market is estimated to grow at a decent CAGR of 5.1% during the forecast period to reach a value of US$ 310 Million in 2027.

Get a free sample report here:

The present report can be of high utility for the key decision-makers and growth strategists in terms of precise market insights, forthcoming growth opportunities, and key success factors. Especially, the report also analyses and mentions the possible impact of COVID-19 on the market dynamics. This will not only help in mitigating the uncertain business environment, but also help in rearranging the strategies and future- decisions in a fruitful manner.

Key Players

The following are some of the key players in the Polyglycolic Acid (PGA) Market:

Kureha Corporation

Corbion

Shenzhen Polymtek Biomaterial Co, Ltd.

BMG Incorporated

Huizhou Foryou Medical Devices Co., Ltd.

Teleflex Incorporated.

Growth drivers and Market Value:

This report, from Stratview Research, studies the Polyglycolic Acid (PGA) Market value and growth drivers over the trend period of 2022-27. According to the report -

Polyglycolic Acid market is likely to witness an impressive CAGR of 9.5% during the forecast period. The growing demand for polyglycolic acid in medical industry, especially as a raw material for manufacturing surgical sutures, hernia meshes, drug delivery devices, grafts, and scaffolds for tissue regeneration, is likely to drive the demand for polyglycolic acid during the forecast period. Higher growth of the packaging industry with preference for biodegradable packaging will also bolster the growth of the market for polyglycolic acid during the forecast period.

Segment Analysis:

Based on Form Type:

Based on the form type, the market is segmented as fibers, films, and others. The fibers segment held the largest share of the market in 2021, and is expected to remain dominant during the forecast period. The higher demand for fiber forms of polyglycolic acid is driving the growth of the segment, with its huge consumption in the medical industry in the formation of absorbable surgical sutures.

Based on Region:

In terms of regions, North America is estimated to be the largest market for polyglycolic acid during the forecast period, with the USA, Canada, and Mexico being the major countries with lucrative growth opportunities. The growth of the market is driven by the presence of old age population along with an increase in the number of cardiac, orthopedic, and hysterectomy surgeries and surge in medical tourism in the region.

Know more about the report, click here

FREQUENTLY ASKED QUESTIONS

The report answers several questions related to the market. The user can get to know the answers to the following questions…

What is the global demand for Polyglycolic Acid (PGA) Market in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fuelling the growth of the market?

Which region accounted for the largest share in the market?

How did the Covid19 impacted the market?

How long will it take to recover from the Covid impact?

Why Stratview Research?

Exhaustive qualitative and quantitative data

Uninterrupted post-sales support

Appropriate market trend and forecast analysis.

All-inclusive report

Decent price-performance ratio

Reliable data

Attractive market segments and associated growth opportunities.

Customised report services

About Us –

Stratview Research is a leading global market research firm providing expert research solutions, trusted by clients worldwide. To keep our clients ahead of the curve, we provide data backed by extensive market research and in-depth industry knowledge. The broad spectrum of integrated insights is referred to, and cited by press releases, interview with key players, white papers, journals, etc. Stratview research also offers custom research services across the sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please connect with our team.

Get in touch with us for more details –

Call: +1-313-307-4176

Or Mail Us: [email protected]

#PolyglycolicAcid(PGA)Market

0 notes

balrajgis · 2 years

Text

Bone Void Fillers Market is expected to witness Incredible Growth during 2021-2031 | Arthrex Inc., Baxter International Inc., Depuy Synthes Companies

Global Bone Void Fillers Market report from Global Insight Services is the single authoritative source of intelligence on Bone Void Fillers Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

A bone void filler is a material that is used to fill in empty spaces in bones. These materials are typically made of synthetic or biological materials. Bone void fillers are used to treat a variety of conditions, including osteonecrosis, non-unions, and congenital defects. The goal of treatment with a bone void filler is to improve the strength and stability of the bone and to provide a scaffold for new bone growth. Bone void fillers are typically used in combination with other treatments, such as surgery, to achieve the best possible outcome.

Get Access to A Free Sample Copy of Our Latest Report – https://www.globalinsightservices.com/request-sample/GIS21605/

Key Trends

The key trends in bone void fillers technology are:

1. The use of biodegradable materials: Biodegradable materials are becoming increasingly popular as bone void fillers because they are absorbed by the body over time, eliminating the need for surgery to remove the implant.

2. The use of natural materials: Natural materials, such as bone grafts from the patient’s own body, are also being used more frequently as bone void fillers.

Key Drivers

The key drivers of the Bone Void Fillers market are the increasing number of hip and knee surgeries, the rising geriatric population, and the growing preference for minimally invasive surgeries. The rising number of hip and knee surgeries is a major driver of the Bone Void Fillers market. Hip and knee surgeries are often required to treat conditions such as osteoarthritis, rheumatoid arthritis, and trauma.

Market Segmentation

By End-Use

Hospital

Specialty Clinics

By Application

Spine Fusion

Bone Fracture

By Type

Demineralized Bone Matrix

Collagen Matrix

By Region

North AmericaUS

Get A Customized Scope to Match Your Need Ask an Expert – https://www.globalinsightservices.com/request-customization/GIS21605

Key Players

Arthrex Inc.

Baxter International Inc.

Depuy Synthes Companies

Medtronic plc

NuVasive Inc.

Orthofix Medical Inc.

Smith and Nephew plc

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions

In-depth segmentation which can be customized as per your requirements

Free consultation with lead analyst of the report

Excel data pack included with all report purchases

Robust and transparent research methodology

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Global Insight Services LLC

16192, Coastal Highway, Lewes DE 19958

E-mail: [email protected]

Phone: +1–833–761–1700

#Bone Void Fillers Market

0 notes

chitrakullkarni · 3 years

Text

Bioprosthetics Market Competitive Landscape, End Use Estimates and Demand

The global Bioprosthetics Market research report provides complete insights on industry scope, trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development.

Market Overview:

Global Bioprosthetics Market is estimated to reach USD 6.41 billion by 2024 due to increase in geriatric population and prevalence of cardiac disorders. Bioprosthetics are the heart valves which are used in clinical practices. They are acquired due to medical implantations or animal tissue. Over the years, bioprosthetics has advanced in the domain. Bioprosthetics not only repair the injured area but also the regenerate sufficiently organized tissue that support angiogenesis and recruit growth factors obtaining the same characteristics of the healthy tissues.

Key Players:

LeMaitre Vascular, Inc.

Braile Biomedica, Inc.

Labcor Laboratorios Ltd.

Maquet Metinge Group

Medtronic Plc.

Aortech International Plc

CryoLife, Inc.

Sorin Group

Humacyte, Inc.

Ethicon, Inc.

LifeCell International

Request free sample to get a complete analysis of top-performing companies @ https://www.millioninsights.com/industry-reports/bioprosthetics-market/request-sample

Growth Drivers:

The factors driving bioprosthetics market are the growing prevalence of rheumatoid heart disorder, cardiac disorders and peripheral artery disorders and consistent demand for medications. The bioprosthetics products are made of biological materials, where the rejection rate in implants is less than as compared to the synthetic implants.

Moreover, the increasing geriatric population with cardiac disorders is stimulating the growth of bioprosthetics industry. Bioprosthetics market is experiencing emergence of new technologies in the field of hybrid tissue-engineered bioprostheses, which uses non-biodegradable cultured tissue scaffolds. These tissues are highly resistant, durable and can be replaced with biodegradable tissue-engineered prosthetics. This technology helps the patients recover and lead a normal life ultimately boosting the market of bioprosthetics in the years to come.

Application Outlook:

Cardiovascular

Plastic surgery & wound healing

Type Outlook:

Allograft

Xenograft

Porcine

Bovine

Regional Outlook:

North America

Canada

Europe

Germany

Asia Pacific

Japan

China

India

Latin America

Mexico

Brazil

MEA

South Africa

Europe is predicted to dominate the market of bioprosthetics owing to several demographic trends like increasing geriatric population, changes in lifestyle, frequent approvals of products, and growing awareness.

Browse Related Category Research Reports @ https://industryanalysisandnews.wordpress.com/

0 notes

nitasonwane · 3 years

Text

Drug Eluting Stents Market Analysis, Development, Revenue, Growth, and Forecast to 2027

The global drug eluting stents (DES) market size is forecast to reach USD 8.98 billion by 2026, attributable to the increasing prevalence of cardiovascular diseases worldwide. A drug eluting stent is a semi-rigid device in the form of a tube that is coated with a drug that helps to prevent reoccurrence or restenosis of an arterial blockage when released. They help to reduce restenosis cases and also limits the risk of late or early thrombosis in patients.

More information on the market is provided in a recently published report by Fortune Business Insights™ titled, “Drug Eluting Stents (DES) Market Size, Share & Industry Analysis, By Type (Coronary Stenting, and Peripheral Stenting), By Product (Polymer-based, and Polymer-free), By Scaffold (Cobalt-Chromium, Platinum-Chromium, Nitinol and Others), By Drug (Sirolimus, Paclitaxel, Zotarolimus, Everolimus, and Others), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2019-2026.” As per this report, the market value was USD 5.71 billion in 2019 and will exhibit a CAGR of 6.7% between 2019 to 2026.

visit: https://www.fortunebusinessinsights.com/drug-eluting-stent-des-market-102612

Improving Healthcare Infrastructure in developing nations will Propel Growth

The increasing cases of cardiovascular diseases worldwide are a significant factor in boosting the global market for drug eluting stents. Besides this, government-supported reimbursement policies and a rise in expenditure on research and development of better stents are also aiding in the expansion of the market. This, coupled with the FDA approvals and CE marks received by many stents, is expected to promote the drug eluting stents market growth in the forecast period.

Rising Incidences of Cardiovascular Diseases will Help Asia Pacific witness Significant Growth

Currently, North America is holding the dominant drug eluting stents market share owing to the increasing prevalence of cardiovascular diseases and the supported reimbursement policies supported by governments in the region. In 2018, this region generated a revenue of USD 1.80 billion. Additionally, the increasing trend of biodegradable polymer-based drug eluting scaffolds may further help this region continue dominance in the forecast period as well. On the other side, the market in Europe will emerge as the fastest-growing region owing to the rise in the number of third-generation DES with the CE mark and the rising popularity of polymer technology for the production of stents. Furthermore, the increasing cases of cardiovascular diseases and the improving medical infrastructure and medical facilities will help Asia Pacific witness significant growth in the coming years.

0 notes

reportr · 3 years

Text

Polyglycolic Acid (PGA) Market Size, Share, Growth, Trends, Company Analysis, Regional Insights and Forecast 2020 - 2027

Market Highlights

The Global Polyglycolic Acid Market is estimated to be valued at USD 1,989,577.9 Thousand by 2030, registering a CAGR of 10.45%.

The growth of the global market is mainly driven by the growing adoption of the product in shale gas exploration and production. The increasing demand for natural gas due to the growth in the demand for energy is expected to boost the shale gas production, which in turn is projected to propel the demand for PGA during the forecast period. The market players are emphasizing on expanding their production capacity to meet the growing demand for PGA in major end-use industries. Likewise, the increasing demand for the product in the healthcare industry is also expected to boost the market growth. Nevertheless, the increasing adoption of the product in the packaging industry and the development of new technologies for PGA production are expected to create growth opportunities for the players operating in the market.

However, the availability of substitutes and high cost of the finished product are factors likely to hamper the global market growth during the forecast period.

Segment Analysis

The global polyglycolic acid market has been segmented on the basis of form, application, and region. On the basis of form, the global market has been divided into fiber, film, and others. The fiber segment accounted for the largest market share, valued at USD 5,10,503.8 thousand in 2018 and is expected to register 10.59% CAGR during the review period. The growth is attributed to the increasing use of fiber in the manufacturing of products used in the oil & gas and medical industries such as PGA bars for frac plugs, frac balls, and medical sutures to reinforce biodegradable composites, weave fabrics, meshes, and scaffolds for tissue engineering. With the increase in shale gas extraction activities, the demand for frac plugs is likely to increase and thus for PGA fibers. The film segment is expected to register 10.13% CAGR by the end of 2030. The use of PGA films is increasing in the packaging industry in PET bottles, packaged food products, toiletry bottles, and beverages due to their superior properties such as excellent gas barrier properties, relatively high strength, and excellent biodegradability.

Based on application, the global market has been segmented into medical, oil & gas extraction, packaging, and others. In terms of value, the medical segment accounted for the largest share of the global polyglycolic acid market in 2018 and is expected to register 9.71% CAGR during the review period, while oil and gas extraction segment accounted for the second-largest market share, valued at USD 2,19,433.6 thousand in 2018 and is expected to register a CAGR of 11.46% during the review period. In terms of volume, the oil & gas extraction segment accounted for the largest market share, pegged at 983.9 tons in 2018 and is expected to register 10.15% CAGR during the review period, while the medical segment was pegged at 526.6 tons in 2018 and is expected to reach 1,286.2 tons by end of 2030.

Access Report Details @

https://www.marketresearchfuture.com/reports/polyglycolic-acid-market-5749

Market Players

Market Research Future (MRFR) recognizes Kureha Corporation (Japan), BMG Incorporated (Japan), Teleflex Inc (US), Corbion N.V. (The Netherlands), Huizhou Foryou Medical Devices Co., Ltd (China), and Shenzhen Polymtek Biomaterial Co., Ltd (China) as the key players in the global polyglycolic acid market.

Regional Analysis

The global polyglycolic acid market, by region, has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

As per MRFR analysis, North America held the largest market share of 60.7 % in 2018 and is expected to register 11.16% CAGR during the review period. The market in Europe accounted for the second-largest share in 2018 and is expected to register 10.21% CAGR during the review period. The market in Asia-Pacific was valued at USD 80,470.7 in 2018 and is expected to reach to USD 2,06,365.2 by end of 2030 on account of growing major end-use industries such as oil & gas, packaging, and medical device.

Key Findings of the Study:

The Global Polyglycolic Acid Marketis projected to reach over USD 1,989,577.91 thousand by 2030 at a 45% CAGR during the review period of 2019 to 2030.

North America accounted for the largest market share, with the US being the major contributor to the growth of the market.

The oil and gas extraction segment is projected to register the highest CAGR during the review period on account of expanding shale gas extraction activities, particularly, in North America.

Get A Sample Report copy Here @

https://www.marketresearchfuture.com/sample_request/5749

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Phone: +16468459312

Email: [email protected]